Entity Details

Primary name FDX2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ6P4F2
EntryNameFDX2_HUMAN
FullNameFerredoxin-2, mitochondrial
TaxID9606
Evidenceevidence at protein level
Length186
SequenceStatuscomplete
DateCreated2008-03-18
DateModified2021-06-02

Ontological Relatives

GenesFDX2

GO terms

Show/Hide Table
GOName
GO:0005759 mitochondrial matrix
GO:0006124 ferredoxin metabolic process
GO:0006700 C21-steroid hormone biosynthetic process
GO:0009055 electron transfer activity
GO:0016125 sterol metabolic process
GO:0046872 metal ion binding
GO:0051537 2 iron, 2 sulfur cluster binding

Subcellular Location

Show/Hide Table
Subcellular Location
Mitochondrion
Mitochondrion matrix

Domains

Show/Hide Table
DomainNameCategoryType
IPR001041 2Fe-2S ferredoxin-type iron-sulfur binding domainDomainDomain
IPR001055 AdrenodoxinFamilyFamily
IPR012675 Beta-grasp domain superfamilyFamilyHomologous superfamily
IPR018298 Adrenodoxin, iron-sulphur binding siteSiteBinding site
IPR036010 2Fe-2S ferredoxin-like superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
251900 OMIMMitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy (MEOAL)An autosomal recessive neuromuscular disorder characterized by childhood onset of recurrent episodes of proximal weakness and myalgia often precipitated by exercise, infections or low temperature. Additional features are optic atrophy, axonal polyneuropathy, and reversible or partially reversible leukoencephalopathy. The disease is caused by variants affecting the gene represented in this entry.

Interactions

4 interactions